Head to head
Cadre Holdings vs SpaceX
Side-by-side on the measures that matter, with a plain-English read. Full detail: CDRE · SPCX
CDRE
Cadre Holdings
24.78-0.78%
1-year price shape — -33% over the period
Quant Rating C · 64/100
vs
SPCX
SpaceX
165.68-1.15%
1-year price shape — not enough history yet
Quant Rating C · 0/100
1-year performance, rebased to 100
Cadre Holdings edges it on the scoreable measures. Cadre Holdings has the highest Quant Rating (64); Cadre Holdings pays the highest dividend yield; Cadre Holdings earns the most per share.
| CDRE | SPCX | |
|---|---|---|
| Snapshot | ||
| Sector | Aerospace & Defense | Aerospace & Defense |
| Last price | 24.78 | 165.68 |
| Change today | -0.78% | -1.15% |
| 1-year return | -32.9% | -- |
| Market cap | $1.06B | $2.18T |
| 52-week range | 24.42 – 48.44 | 104.83 – 225.64 |
| Valuation | ||
| P/E (TTM) | 30.59 | -245.45 |
| P/E percentile, own 5-yr range | 19th | 6th |
| P/B | 3.06 | 17.16 |
| Dividend yield | 1.57% | 0.00% |
| Profitability & growth | ||
| EPS (TTM) | 1.02 | -0.38 |
| Net profit (TTM) | $43.68M | $-4.98B |
| Revenue (TTM) | $685.65M | $20.65B |
| Revenue growth (YoY) | +31.8% | +91.9% |
| Gross margin | 41.8% | 51.9% |
| Operating margin | 11.1% | -14.9% |
| Net margin | 5.3% | -38.6% |
| Free cash flow (TTM) | $78.12M | $-32.52B |
| Ownership & sentiment | ||
| Institutional ownership | 78.5% | 29.8% |
| Insider activity (12mo) | 24 buy / 24 sell | 5 buy / 5 sell |
| Short interest (% of float) | 5.3% | 1.2% |
| Analyst consensus | 83% buy / 17% sell (6) | 87% buy / 7% hold / 7% sell (30) |
| Analyst price target | $44 (+79%) | $245 (+48%) |
| StockVane view | ||
| StockVane Quant Rating | C (64) | C (0) |
| Company | ||
| Employees | 2,533 | 22,000 |
| Founded | 2012 | 2002 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.